These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Whole-Body Atherosclerosis Imaging by Positron Emission Tomography/Magnetic Resonance Imaging: From Mice to Nonhuman Primates. Calcagno C; Pérez-Medina C; Mulder WJM; Fayad ZA Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1123-1134. PubMed ID: 32237905 [TBL] [Abstract][Full Text] [Related]
24. Noninvasive assessment of hypoxia in rabbit advanced atherosclerosis using ¹⁸F-fluoromisonidazole positron emission tomographic imaging. Mateo J; Izquierdo-Garcia D; Badimon JJ; Fayad ZA; Fuster V Circ Cardiovasc Imaging; 2014 Mar; 7(2):312-20. PubMed ID: 24508668 [TBL] [Abstract][Full Text] [Related]
25. The value of imaging in subclinical coronary artery disease. Zimarino M; Prati F; Marano R; Angeramo F; Pescetelli I; Gatto L; Marco V; Bruno I; De Caterina R Vascul Pharmacol; 2016 Jul; 82():20-9. PubMed ID: 26851577 [TBL] [Abstract][Full Text] [Related]
27. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque. MacAskill MG; Newby DE; Tavares AAS Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100 [TBL] [Abstract][Full Text] [Related]
28. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease. Stolzmann P; Subramanian S; Abdelbaky A; Maurovich-Horvat P; Scheffel H; Tawakol A; Hoffmann U Radiographics; 2011; 31(5):1255-69. PubMed ID: 21918043 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of 68Ga-Glutamate Carboxypeptidase II Ligand Positron Emission Tomography for Clinical Molecular Imaging of Atherosclerotic Plaque Neovascularization. Derlin T; Thiele J; Weiberg D; Thackeray JT; Püschel K; Wester HJ; Aguirre Dávila L; Larena-Avellaneda A; Daum G; Bengel FM; Schumacher U Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2213-2219. PubMed ID: 27609368 [TBL] [Abstract][Full Text] [Related]